Log in to save to my catalogue

Eplerenone for chronic central serous chorioretinopathy – Authors' reply

Eplerenone for chronic central serous chorioretinopathy – Authors' reply

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2460999694

Eplerenone for chronic central serous chorioretinopathy – Authors' reply

About this item

Full title

Eplerenone for chronic central serous chorioretinopathy – Authors' reply

Publisher

London: Elsevier Ltd

Journal title

The Lancet (British edition), 2020-11, Vol.396 (10262), p.1557-1558

Language

English

Formats

Publication information

Publisher

London: Elsevier Ltd

More information

Scope and Contents

Contents

[...]Sacconi and colleagues state that “the presence of a hotspot in the late phase of indocyanine green angiography seems to indicate a positive response to eplerenone” and cite their own non-randomised study2 of 29 patients to support this assertion. [...]Stanescu-Segall and colleagues conclude that “The safety and side-effects of eplerenone are...

Alternative Titles

Full title

Eplerenone for chronic central serous chorioretinopathy – Authors' reply

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2460999694

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2460999694

Other Identifiers

ISSN

0140-6736

E-ISSN

1474-547X

DOI

10.1016/S0140-6736(20)32321-7

How to access this item